Specific pathological reporting is necessary in patients going through neoadjuvant systemic therapy (NST). There exist a minimum of 5 unique reporting scores for that grade of remission after NST; Many of these, having said that, are only validated for inflammatory breast cancer (e.Oncoplastic surgical procedure is an essential element in the thera